HIVID 0.375 (Hivid 0.375 MG)

Generic Name: zalcitabine

Pill with imprint HIVID 0.375 is Pink, Elliptical / Oval and has been identified as Hivid 0.375 MG. It is supplied by Roche Laboratories.

Hivid is used in the treatment of hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Hivid 0.375 MG is not a controlled substance under the Controlled Substances Act (CSA).

Images for HIVID 0.375

Hivid

Generic Name:

zalcitabine

Imprint:

HIVID 0.375

Strength:

0.375 MG

Color:

Pink

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Nucleoside reverse transcriptase inhibitors (NRTIs)

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Roche Laboratories

National Drug Code (NDC):

00004-0220

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer